EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Heart Transplantation Outcomes with Donation After Circulatory Death in Patients with Left Ventricular Assist Device

Aris Karatasakis, Edwin Grajeda Silvestri, Gatha G Nair, Benjamin Zuniga, Song Li, Claudius Mahr, Richard K Cheng, April S Stempien-Otero, Ioannis Dimarakis, Maziar Khorsandi, Jay D Pal, Jorge R Kizer und 2 weitere

ESC Heart Failure · 01.10.2025 · 12 (5) · 3333-3342

DOI: 10.1002/ehf2.15357 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift ESC Heart Failure, online erschienen am 26.06.2025. Verfasst von Aris Karatasakis und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, University of Washington Medical Center, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Heart-Assist Devices, Heart Transplantation, Heart Failure, Tissue Donors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: HCA Healthcare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Donation after circulatory death (DCD) has emerged as a strategy to increase the donor pool for heart transplantation (HT). Left ventricular assist device (LVAD) patients represent a discrete and unique population. We sought to explore the early outcomes of DCD-HT compared with donation after brain death (DBD) HT in LVAD patients. Methods and results We obtained data from the United Network of Organ Sharing database. The main cohort consisted of adults listed for HT between 17 October 2018 and 3 July 2024, with LVAD implanted before or after listing. The primary outcome was survival within the first year post-HT. There were 3336 patients with LVAD underwent HT during the study period (median age 55 years (interquartile range 45–62), 24% women, 29% Black, 89% DBD). The short-term post-HT mortality in LVAD patients who underwent DCD HT was not significantly different from DBD (adjusted hazard ratio [aHR] 1.00, 95% CI 0.70–1.42, P value > 0.9). The likelihood of transplantation within 1 year was higher at centres performing DCD (aHR 1.44, 95% CI 1.39–1.49, P < 0.001). Despite the longer donor-recipient distance in DCD-HT, in-hospital outcomes (stroke and acute kidney injury requiring dialysis) were not different from DBD-HT. A higher incidence of primary graft dysfunction (adjusted risk ratio [aRR] 3.8, 95% CI 2.5–5.7, P < 0.001), and treated rejection was observed with DCD-HT (aRR 1.48, 95% CI 1.14–1.93, P = 0.003).

Conclusions

In LVAD patients who received DCD HT, early post-transplant survival, stroke, acute kidney injury and length of stay were not significantly different from those who underwent DBD HT. There were increased rates of primary graft dysfunction and treated rejection among LVAD patients who underwent DCD HT. Patients in a DCD centre were significantly more likely to be transplanted earlier.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart-Assist DevicesHeart TransplantationHeart FailureTissue DonorsTissue and Organ ProcurementHumansFemaleMaleMiddle AgedRetrospective StudiesSurvival RateFollow-Up StudiesAdultUnited States

Stichwörter der Autor:innen

Donation after brain deathDonation after circulatory deathHeart transplantationLeft ventricular assist device

Autor:innen und Institutionen

  • Division of Cardiology, University of Washington Medical Center, Seattle, Washington, USA.
  • Presbyterian Heart & Vascular Care, Albuquerque, New Mexico, USA.
  • Division of Cardiology, Rush University Medical Center, Chicago, Illinois, USA.
  • Department of Internal Medicine, University of Connecticut, Farmington, Connecticut, USA.
  • Institute for Advanced Cardiac Care, Medical City Healthcare, Dallas, Texas, USA.
  • Division of Cardiothoracic Surgery, University of Washington Medical Center, Seattle, Washington, USA.

ORCID-Profile: Claudio A Bravo

Förderung

  • HCA Healthcare

Zitieren

APA

Karatasakis, A., Silvestri, E. G., Nair, G. G., Zuniga, B., Li, S., Mahr, C., Cheng, R. K., Stempien-Otero, A. S., Dimarakis, I., Khorsandi, M., Pal, J. D., Kizer, J. R., Simon, M. A., & Bravo, C. A. (2025). Heart Transplantation Outcomes with Donation After Circulatory Death in Patients with Left Ventricular Assist Device. ESC Heart Failure, 12(5), 3333-3342. https://doi.org/10.1002/ehf2.15357

Vancouver

Karatasakis A, Silvestri EG, Nair GG, Zuniga B, Li S, Mahr C, et al. Heart Transplantation Outcomes with Donation After Circulatory Death in Patients with Left Ventricular Assist Device. ESC Heart Failure. 2025;12(5):3333-3342. doi:10.1002/ehf2.15357

BibTeX
@article{Karatasakis2025,
  author = {Karatasakis, Aris and Silvestri, Edwin Grajeda and Nair, Gatha G and Zuniga, Benjamin and Li, Song and Mahr, Claudius and Cheng, Richard K and Stempien-Otero, April S and Dimarakis, Ioannis and Khorsandi, Maziar and Pal, Jay D and Kizer, Jorge R and Simon, Marc A and Bravo, Claudio A},
  title = {Heart Transplantation Outcomes with Donation After Circulatory Death in Patients with Left Ventricular Assist Device},
  journal = {ESC Heart Failure},
  year = {2025},
  volume = {12},
  number = {5},
  pages = {3333--3342},
  doi = {10.1002/ehf2.15357}
}
Kostenlos starten →